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we report that the downregulation of histone deacetylase 6 (HDAC6) causes a reduction in the net
activity of mitochondrial enzymes, including respiratory complex II and citrate synthase. HDAC6
deacetylase and ubiquitin-binding activities were both required for recovery of reduced mitochon-
drial metabolic activity due to the loss of HDAC6. Hsp90, a substrate of HDAC6, localizes to mito-
chondria and partly mediates the regulation of mitochondrial metabolic activity by HDAC6. Our
ﬁnding suggests that HDAC6 regulates mitochondrial metabolism and might serve as a cellular
homeostasis surveillance factor.
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Multiple biological functions of HDAC6 have been unveiled
since the identiﬁcation of histone deacetylase 6 (HDAC6) as a cyto-
plasmic deacetylase [1,2]. Early studies found that HDAC6-medi-
ated a-tubulin deacetylation destabilizes dynamic microtubules
[3] and promotes an increase in cell motility [4,5]. In addition to
a-tubulin, several cytoplasmic proteins including Hsp90 [6,7],
cortactin [8], b-catenin [9], peroxiredoxins I and II [10], and Ku70
[11] are regulated in a HDAC6-mediated deacetylation-dependent
manner. Strong ubiquitin binding activity [12,13] further adds to
the multifunctionality of HDAC6, enabling the regulation of many
important processes including cell migration, cell stress response
to the cytotoxic accumulation of protein aggregates, and immune
synapse formation [1,2].chemical Societies. Published by E
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p (K. Kamemura).Here, we report the depression of mitochondrial metabolism by
downregulation of HDAC6. Our ﬁndings uncover a novel function
of HDAC6 as a homeostasis surveyor of the cell.
2. Materials and methods
2.1. Cell culture
All cells were maintained in DMEM supplemented with 10%
heat-inactivated fetal calf serum. An established A549 cell line
expressing RNAi for HDAC6 (HDAC6-KD), and HDAC6-KD cells re-
introduced with wild type HDAC6 (KD +WT), catalytically inactive
(KD + DC), or ubiquitin binding-deﬁcient mutant (KD + DUBD)
have been described previously [14]. HDAC6-deﬁcient mouse
embryonic ﬁbroblast (MEF) cell line is described in the literature
[15].
2.2. XTT assay
Cells were seeded in triplicate onto 96-well plates at the
indicated density. The cleavage of XTT, sodium 30-[1-[(phenylami-
no)-carbonyl]-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene-lsevier B.V. All rights reserved.
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Fig. 1. Reduction of net mitochondrial metabolic activity in HDAC6-depleted cells. (A) XTT assay of HDAC6-depleted A549 cells. Data are presented as means ± standard
deviation (S.D.) from three independent assays. ⁄P < 0.01. HDAC6-KD, stable HDAC6-knockdown cells; pS, control cells for knockdown treatment. (B) XTT assay of HDAC6-
depleted A549 cells treated for 6 h with 1 or 10 mM of 3-nitropropionic acid (3-NP). Data are presented as means ± S.D. (n = 3). (C) XTT assay of HDAC6-deﬁcient mouse
embryonic ﬁbroblasts (MEFs). Data are presented as means ± S.D. (n = 3, ⁄P < 0.01, ⁄⁄P < 0.024). 609, wild type MEFs; 615, HDAC6-deﬁcient MEFs. (D) The citrate synthase (CS)
activity of HDAC6-depleted A549 cells. Data are presented as means ± S.D. (n = 3, ⁄P < 0.03). (E) The CS activity of HDAC6-deﬁcient MEFs. Data are presented as means ± S.D.
(n = 3, ⁄P < 0.01).
1380 K. Kamemura et al. / FEBS Letters 586 (2012) 1379–1383sulfonic acid hydrate, by dehydrogenases in cells was measured
after 8 h using Cell Proliferation Kit II (Roche). Plates were analyzed
in a microtiter plate reader at 492 nm with a reference wavelength
of 620 nm.
2.3. Citrate synthase (CS) assay
Cells were lysed (1  106 cells/200 ll) in a buffer containing
0.1% Triton X-100, 1 mM EDTA, 50 mM Tris, pH 7.4, and Protease
Inhibitor Cocktail (Nacalai Tesque). The CS assay was carried out
using 20 ll of the lysates in 96-well plates. CS activity was mea-
sured by adding 80 ll of the reaction solution containing 0.1 mM
DTNB, 0.3 mM acetyl-CoA, 1 mM oxaloacetate, and 50 mM Tris at
pH 7.4 to each well. Absorbance was measured at 405 nm every
15 s for 10 min using the kinetic mode of a microtiter plate reader.
Total protein concentration of the lysates was quantiﬁed by a Bio-
Rad Protein Assay, and CS activity was normalized to the total
protein concentration. CS activity was calculated as the rate of in-
crease of absorbance with time.
2.4. Western blotting
Cells were lysed in SDS–polyacrylamide gel electrophoresis
(PAGE) sample buffer. To detect proteins in Western blots, the
samples were run on SDS–PAGE, electroblotted onto a polyvinyli-
dene diﬂuoride membrane (Millipore), and subjected to immuno-
detection using the appropriate primary antibody. Proteins werevisualized by using horseradish peroxidase-linked secondary anti-
body and enhanced chemiluminescence.
2.5. Subcellular fractionation and proteinase-sensitivity assay
Cells (90% conﬂuence on a 15 cm dish) were collected and sus-
pended in HEMS buffer consisting of 10 mM Hepes-KOH, pH 7.4,
1 mM EDTA, 220 mM mannitol, and 70 mM sucrose. Cells were
then homogenized by a dounce homogenizer (7 ml) and conven-
tional subcellular fractionation techniques were applied to homog-
enates as described previously [16].
The proteinase-sensitivity assay was performed as described
previously [17], using HEMS buffer. Mitochondria (10 lg) were
treated with proteinase K at the indicated concentrations.
3. Results and discussion
3.1. HDAC6 expression correlates with mitochondrial metabolic
activity
We have previously demonstrated that knockdown of HDAC6
expression causes a decrease in the steady-state levels of growth
factor receptors [18]. During the study, we noticed that the down-
regulation of HDAC6 inﬂuences mitochondrial metabolic activity.
To conﬁrm the effect of HDAC6 downregulation on mitochondrial
metabolism, we ﬁrst examined XTT assay-based dehydrogenase
activity in HDAC6-KD cells. The net activity of dehydrogenases
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Fig. 2. Both deacetylase and ubiquitin binding activities of HDAC6 are linked to the
regulation of mitochondrial metabolic activity. (A) Protein expression levels of re-
introduced wild type and mutant HDAC6. Whole cell lysates were immunoblotted
with anti-FLAG antibody. a-Tubulin was used as loading control. The established cell
lines used were HDAC6-KD cells re-introduced with wild type (KD +WT), catalyt-
ically inactive (KD + DC), and ubiquitin binding-deﬁcient mutant (KD + DUBD) of
HDAC6. KD + Neo were control cells for re-introduction treatment. (B) XTT assay of
HDAC6-KD cells re-introducedwith HDAC6. Cells were seeded at a density of 1  104
cells/well. Data are presented as means ± S.D. (n = 3).
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Fig. 3. HDAC6 depletion does not affect the expression levels of nuclear-encoded
mitochondrial enzymes. (A) Whole cell lysates from pS or HDAC6-KD cells were
immunoblotted for the indicated proteins. (B) Whole cell lysates from HDAC6-
deﬁcient MEFs (615) or control MEFs (609) were immunoblotted for the indicated
proteins. SDHA, complex II subunit 70 kDa Fp; SDHB, complex II subunit 30 kDa Ip;
F1a, complex V ATP synthase subunit a (as a mitochondrial control). a-Tubulin was
used as a loading control. An asterisk indicates a non-speciﬁc signal.
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Fig. 4. HDAC6 is distributed throughout the cytoplasm, and its substrate Hsp90
localizes in both the cytoplasm and mitochondria. (A) Both mitochondrial and
cytosolic fractions were prepared from A549 cells stably expressing FLAG-tagged
wild type HDAC6, and then immunoblotted with the indicated antibodies.
Subcellular fractionation was conﬁrmed by immunoblotting both fractions for
Hsp70 (cytosolic protein) and ATP synthase b (mitochondrial protein). (B)
Mitochondrial fractions from both HDAC6-KD and pS cells were subjected to a
proteinase-sensitivity assay, and then immunoblotted with the indicated antibod-
ies. Tom20 was used as a mitochondrial outer membrane protein, and Hsp60 as a
mitochondrial matrix protein. Tx, 1% Triton X-100. Pro K, proteinase K. Asterisks
indicate cleavage products. (C) The relative mitochondrial activity in radicicol-
treated pS or HDAC6-KD cells. The mitochondrial metabolic activity of pS or
HDAC6-KD cells treated for 24 h with DMSO or 100 lM of radicicol was measured
by the XTT assay. After correcting with cell numbers measured by calcein-AM
staining, the relative mitochondrial activity was calculated by dividing the
mitochondrial activity of radicicol-treated cells by the activity of DMSO control
cells. Data are presented as means ± S.D. (n = 5, ⁄P < 0.005).
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trol cells (A549 cells and pS cells; Fig. 1A). Succinate dehydrogenase
is the major dehydrogenase responsible for formazan formationfrom XTT in mitochondrial respiratory complex II. In fact, 3-NP,
an irreversible inhibitor of succinate dehydrogenase, reduced the
XTT reaction in both pS and HDAC6-KD cells (Fig. 1B). In addition,
HDAC6-deﬁcient MEFs (615) also showed much lower dehydroge-
nase net activity than wild type MEFs (609) in the assay (Fig. 1C).
We next examined mitochondrial oxidative capacity in HDAC6-
KD cells using CS activity as a marker. CS activity in HDAC6-KD cells
was reduced by 30% compared with that in pS cells (Fig. 1D). Com-
pared with wild type MEFs, CS activity was also reduced by 60% in
HDAC6-deﬁcient MEFs (Fig. 1E). Consistent with our results, a gen-
1382 K. Kamemura et al. / FEBS Letters 586 (2012) 1379–1383ome-wide RNAi screening recently indicated that the knockdown of
HDAC6 expression inDrosophila S2 cells correlated with a reduction
in CS activity [19]. Thus HDAC6 expression correlates with mito-
chondrial metabolic activity in both insect and mammalian cells,
and HDAC6 might have a role in the regulation of mitochondrial
metabolic activity.
3.2. Both deacetylase and ubiquitin binding activities of HDAC6 are
linked to the regulation of mitochondrial metabolic activity
HDAC6 is a cytoplasmic deacetylase which has double deacetyl-
ase domains and an ubiquitin binding domain [1,2,20]. To gain in-
sight into the relevance of HDAC6 for mitochondrial metabolic
activity, we tested the activities of HDAC6 to reveal which of these
is required for the regulation of mitochondrial metabolic activity.
We examined the net dehydrogenase activity in HDAC6-KD cells
re-introduced with wild type (KD +WT), catalytically inactive
(KD + DC), or ubiquitin binding-deﬁcient mutants (KD + DUBD) of
HDAC6 (Fig. 2A). The reduced net activity of dehydrogenases in
HDAC6-KD cells was fully recovered by the introduction of wild
type HDAC6, but not by catalytically inactive or ubiquitin bind-
ing-deﬁcient mutants (Fig. 2B). This result indicates that both
deacetylase and ubiquitin binding activities of HDAC6 participate
in the regulation of mitochondrial metabolic activity.
3.3. Loss of HDAC6 does not affect the expression levels of nuclear-
encoded mitochondrial enzymes
Several lines of evidence have shown that HDAC6 affects the
transcriptional activities of various factors despite its cytoplasmic
localization [20]. The subunits of complex II and CS are nuclear-en-
coded mitochondrial enzymes; therefore, the reduction in their
metabolic activities in HDAC6-depleted cells might be due to de-
creased gene expression in the absence of HDAC6. However, the
expression levels of the complex II subunits, SDHA and SDHB,
and CS were not affected by either knockdown of HDAC6 expres-
sion (Fig. 3A) or HDAC6 deﬁciency (Fig. 3B). In addition, both the
mitochondrial mass and the apparent distribution of mitochondria
in HDAC6-KD cells and HDAC6-deﬁcient MEFs were indistinguish-
able from those of control cells (data not shown), indicating that
mitochondrial biogenesis overall is unaffected by the loss of
HDAC6.
3.4. HDAC6 regulates mitochondrial metabolic activity in the
cytoplasm
A biochemical subcellular fractionation study showed that
HDAC6 is distributed throughout the cytoplasm but not to the
mitochondria (Fig. 4A). This indicates that HDAC6 may regulate
mitochondrial metabolic activity from the cytoplasm. Of the
known substrates of HDAC6, Hsp90 may be linked with the
HDAC6-mediated regulation of mitochondrial metabolic activity.
Inactivation of HDAC6 leads to hyperacetylation of Hsp90 and
instability of its client proteins [6,7]. Interestingly, Kang et al. have
found that an abundant pool of Hsp90 localizes to mitochondria in
various tumor cells and regulates mitochondrial integrity [21]. We
also found a considerable amount of Hsp90, especially Hsp90a, in
the mitochondrial fraction of both A549 cells (Fig. 4A) and MEFs
(data not shown). Next we performed the proteinase K sensitivity
assay using isolated mitochondrial fractions. Tom20, the mito-
chondrial outer membrane marker, was sensitive to proteinase K
at a concentration of 0.1 lg/ml, whereas Hsp60, the mitochondrial
matrix marker, was insensitive at that concentration, and large
portions were degraded at concentrations above 5 lg/ml in both
HDAC6-KD and control cells (Fig. 4B). Under these experimental
conditions, most portions of Hsp90awere insensitive to proteinaseK treatment at a concentration of 0.1 lg/ml in both HDAC6-KD and
control cells, which is reminiscent of the sensitivity of Hsp60 to
proteinase K. These results indicate that Hsp90a localizes to the
inner space of the mitochondrial outer membrane, probably the
matrix and intermembrane space, where most mitochondrial met-
abolic enzymes are located. This suggests that the reduction of
mitochondrial metabolic activity from loss of HDAC6 is due in part
to increased acetylation and inactivation of Hsp90. In fact, Hsp90
inhibitor radicicol reduced mitochondrial metabolic activity
slightly, but signiﬁcantly, in control cells but not in HDAC6-KD
cells (Fig. 4C). Thus, we conclude that HDAC6 controls mitochon-
drial metabolic activity partly through deacetylation of Hsp90.
In addition to deacetylase activity, the ubiquitin binding activity
of HDAC6 is simultaneously involved in the regulation of mito-
chondrial metabolic activity (Fig. 2). Mitochondrial protein quality
control is regulated by the mitochondria-associated degradation
pathway [22]. In this pathway, p97/VCP is recruited to stressed
mitochondria and extracts ubiquitinated proteins from the outer
mitochondrial membrane to the cytoplasm to present them to
the proteasome for degradation [22]. Because p97/VCP is a known
partner of HDAC6 [12] and regulates the fate of ubiquitinated cel-
lular proteins together with HDAC6 [23], the reduced mitochon-
drial metabolic activity through loss of HDAC6 may be attributed
to the stagnation of mitochondrial protein quality control. At pres-
ent, we do not have any direct evidence demonstrating a link be-
tween deacetylase and ubiquitin binding activity of HDAC6 for
the regulation of mitochondrial metabolic activity. We speculate,
however, that together these two HDAC6 activities regulate mito-
chondrial metabolic activity because the lowered mitochondrial
metabolic activity in HDAC6-KD cells fully recovered only by the
introduction of wild type HDAC6 (Fig. 2).
Since mitochondria perform multiple functions critical to the
maintenance of cellular homeostasis, the reduction of mitochon-
drial metabolism may impose a restriction of energy consumption
on the cell. Indeed, loss of HDAC6 causes a reduction in cell motil-
ity both in NIH/3T3 ﬁbroblasts [4,5] and lymphocytes [24]. HDAC6
may thus be a cellular homeostasis surveillance factor. It was pro-
posed very recently that histone-modifying enzymes including
kinases, acetyltransferases, methyltransferases, and O-GlcNAc
transferase interpret the metabolic state of a given cell by changing
chromatin modiﬁcation patterns [25]. This proposal led us to the
idea that HDAC6 could control the state of the epigenome through
the control of mitochondrial metabolism. The functional relevance
of HDAC6-mediated regulation of mitochondrial metabolism to
epigenetics is an attractive issue yet to be unveiled.Acknowledgments
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